Please provide your email address to receive an email when new articles are posted on . Researchers assessed patients receiving omalizumab, dupilumab, mepolizumab, benralizumab, reslizumab or ...
Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...
News-Medical.Net on MSN
New CHEST guidelines offer evidence-based biologic selection for severe asthma
The American College of Chest Physicians ® (CHEST) recently released a new clinical guideline on biologic management in ...
Earlier initiation of biologics in severe asthma could prevent thousands of deaths and save billions in healthcare costs by reducing exacerbations and healthcare resource utilization. Real-world data ...
Biologics used as an asthma treatment also appear to improve symptoms of coexisting chronic rhinosinusitis in some patients, according to results from a real-world study published in the International ...
Biologic therapies for asthma and CRSwNP may reduce ear-related symptoms, including otitis media, ear fullness, pain, and dizziness. A retrospective analysis showed significant improvements in ...
Please provide your email address to receive an email when new articles are posted on . Less than 15% of PCPs reported managing patients with uncontrolled asthma at least once a week. More PCPs ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
VIENNA — Physicians are called to record clinical details of patients with asthma undergoing biologic therapy to monitor clinical remission and keep an eye on eosinophilic granulomatosis with ...
New treatment offered at St. Barnabas Hospital may be able to change the lives of some asthma sufferers. Asthma rates in the Bronx are among the highest in the country. St. Barnabas' biologic therapy ...
PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) said the U.S. Food and Drug Administration has approved Exdensur, a twice-yearly biologic treatment for patients with severe asthma characterized by an ...
Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet in Sweden shows that some immune cells with high inflammatory potential are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results